Altogether, our results indicated that traditional chemotherapy may not improve immune‐mediated anti‐tumor effects in patients with PTCL, while chidamide combined traditional chemotherapy can enhance immune‐mediated anti‐tumor effects of PD‐1 (+) cells. This evidence concerns the gene PDCD1 and mature T-cell and NK-cell non-Hodgkin lymphoma.